Successful MDR-TB treatment regimens including Amikacin are associated with high rates of hearing loss

BACKGROUND: Aminoglycosides are a critical component of multidrug-resistant tuberculosis (MDR-TB) treatment but data on their efficacy and adverse effects in Botswana is scarce. We determined the effect of amikacin on treatment outcomes and development of hearing loss in MDR-TB patients. METHODS: Pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Modongo, Chawangwa, Sobota, Rafal S, Kesenogile, Boikobo, Ncube, Ronald, Sirugo, Giorgio, Williams, Scott M, Zetola, Nicola M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287509/
https://www.ncbi.nlm.nih.gov/pubmed/25300708
http://dx.doi.org/10.1186/1471-2334-14-542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287509/
https://www.ncbi.nlm.nih.gov/pubmed/25300708
http://dx.doi.org/10.1186/1471-2334-14-542

Ejemplares similares